{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:46:21Z","timestamp":1791881181415,"version":"4.3.4"},"reference-count":42,"publisher":"Bentham Science Publishers Ltd.","issue":"16","funder":[{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation General Project","doi-asserted-by":"publisher","award":["2023JJA141341"],"award-info":[{"award-number":["2023JJA141341"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The HSP90AA1 gene has been linked to a number of malignancies,\nbut its precise function is still unknown, and no research has examined the connection\nbetween HSP90AA1 and pan-cancer. Therefore, further investigation into the relationship\nbetween HSP90AA1 and pan-cancer is required.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We utilized the human protein atlas (HPA) to analyze HSP90AA1 mRNA and\nprotein expression levels in human organs, tissues, and cell lines. Subsequently, the 33\ndifferent cancer types' levels of HSP90AA1 mRNA expression were assessed, and a\nrange of tumor types had their diagnostic and prognostic values assessed. Additionally,\nthe regions with the most prevalent HSP90AA1 mutation types were found.\nHSP90AA1's PPI and miRNA regulatory networks were established, and its activating\nor inhibiting effects in established pathways were examined. Finally, we looked at the\nconnection between immune cell and regulator infiltration levels in various cancers and\nthe expression levels of HSP90AA1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The nasopharynx, testis, fallopian tube, bronchus, duodenum, gallbladder, and\nepididymis are the primary organs that express the HSP90AA1 protein. Thirty-three cancers\nhave elevated HSP90AA1 mRNA expression as compared to normal tissues. The\nmost prevalent HSP90AA1 mutation location is X585. Analysis of HSP90AA1 as a diagnostic\nmarker in pan-cancer showed that the good diagnostic utility of HSP90AA1 in a\nrange of cancer types. High HSP90AA1 expression groups had poorer prognosis and\nwere associated with clinical parameters. GO\/KEGG and GSEA analyses showed that\nHSP90AA1 was mostly associated with pathways that are linked to tumor molecules\nand the immune system. HSP90AA1 was associated with immune cells and regulatory\nfactors in various cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>HSP90AA1 plays a role in immune microenvironment modulation in a\nrange of tumor types and is correlated with prognosis. We hope to further validate the\nrole of HSP90AA1 in tumors through cellular and functional assays, so as to achieve the\nvalidation of the theory, basic experiments, and clinical applications, and thus promote it\nas a recognized prognostic marker. And the development of corresponding targeted\ndrugs for the HSP90AA1 locus may become a major challenging direction for future development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>HSP90AA1 was mostly associated with pathways that are linked to tumor\nmolecules and the immune system, and was considered a potential diagnostic, prognostic,\nand immunological biomarker in human cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673378694251003073322","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:28:02Z","timestamp":1774038482000},"page":"3175-3210","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential of HSP90AA1 as Diagnostic, Prognostic, and Immunological Biomarkers in Human Cancer Demonstrated through Pan-Cancer Investigation: A Bioinformatics Analysis"],"prefix":"10.2174","volume":"33","author":[{"given":"Shubin","family":"Chen","sequence":"first","affiliation":[{"name":"Medical Oncology Of Respiratory, Guangxi Medical University Cancer Hospital, Nanning Guangxi,530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshu","family":"Huang","sequence":"additional","affiliation":[{"name":"Medical Oncology Of Respiratory, Guangxi Medical University Cancer Hospital, Nanning Guangxi,530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Medical Oncology Of Respiratory, Guangxi Medical University Cancer Hospital, Nanning Guangxi,530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozhang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Medical Oncology Of Respiratory, Guangxi Medical University Cancer Hospital, Nanning Guangxi,530021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"Sung H.","year":"2021","unstructured":"Sung H.; Ferlay J.; Siegel R.L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2021,71(3),209-249","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"14810","DOI":"10.1039\/C4NR04589K","volume":"6","author":"Akhavan O.","year":"2014","unstructured":"Akhavan O.; Ghaderi E.; Hashemi E.; Rahighi R.; Ultra-sensitive detection of leukemia by graphene. Nanoscale  2014,6(24),14810-14819","journal-title":"Nanoscale"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jamaoncol.2021.6597","volume":"8","author":"Tarantino P.","year":"2022","unstructured":"Tarantino P.; Curigliano G.; Parsons H.A.; Lin N.U.; Krop I.; Mittendorf E.A.; Waks A.; Winer E.P.; Tolaney S.M.; Aiming at a tailored cure for erbb2-positive metastatic breast cancer: A review. JAMA Oncol  2022,8(4),629-635","journal-title":"JAMA Oncol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S1470-2045(11)70129-2","volume":"13","author":"Yasuda H.","year":"2012","unstructured":"Yasuda H.; Kobayashi S.; Costa D.B.; EGFR exon 20 insertion mutations in non-small-cell lung cancer: Preclinical data and clinical implications. Lancet Oncol  2012,13(1),e23-e31","journal-title":"Lancet Oncol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-018-0810-4","volume":"17","author":"Golding B.","year":"2018","unstructured":"Golding B.; Luu A.; Jones R.; Viloria-Petit A.M.; The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC). Mol Cancer  2018,17(1),52","journal-title":"Mol Cancer"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ygeno.2005.08.012","volume":"86","author":"Chen B.","year":"2005","unstructured":"Chen B.; Piel W.H.; Gui L.; Bruford E.; Monteiro A.; The HSP90 family of genes in the human genome: Insights into their divergence and evolution. Genomics  2005,86(6),627-637","journal-title":"Genomics"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gene.2015.06.018","volume":"570","author":"Zuehlke A.D.","year":"2015","unstructured":"Zuehlke A.D.; Beebe K.; Neckers L.; Prince T.; Regulation and function of the human HSP90AA1 gene. Gene  2015,570(1),8-16","journal-title":"Gene"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.32604\/or.2023.030081","volume":"31","author":"Tang F.","year":"2023","unstructured":"Tang F.; Li Y.; Pan M.; Wang Z.; Lu T.; Liu C.; Zhou X.; Hu G.; HSP90AA1 promotes lymphatic metastasis of hypopharyngeal squamous cell carcinoma by regulating epithelial-mesenchymal transition. Oncol Res  2023,31(5),787-803","journal-title":"Oncol Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1186\/1471-2407-14-629","volume":"14","author":"Shen H.","year":"2014","unstructured":"Shen H.; Zhu H.; Song M.; Tian Y.; Huang Y.; Zheng H.; Cao R.; Lin J.; Bi Z.; Zhong W.; A selenosemicarbazone complex with copper efficiently down-regulates the 90-kDa heat shock protein HSP90AA1 and its client proteins in cancer cells. BMC Cancer  2014,14(1),629","journal-title":"BMC Cancer"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1186\/s12885-022-09596-z","volume":"22","author":"Zhang M.","year":"2022","unstructured":"Zhang M.; Peng Y.; Yang Z.; Zhang H.; Xu C.; Liu L.; Zhao Q.; Wu J.; Wang H.; Liu J.; DAB2IP down-regulates HSP90AA1 to inhibit the malignant biological behaviors of colorectal cancer. BMC Cancer  2022,22(1),561","journal-title":"BMC Cancer"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1158\/1078-0432.CCR-14-0174","volume":"20","author":"Shi Y.","year":"2014","unstructured":"Shi Y.; Liu X.; Lou J.; Han X.; Zhang L.; Wang Q.; Li B.; Dong M.; Zhang Y.; Plasma levels of heat shock protein 90 alpha associated with lung cancer development and treatment responses. Clin Cancer Res  2014,20(23),6016-6022","journal-title":"Clin Cancer Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/cells9010144","volume":"9","author":"Gong Y.","year":"2020","unstructured":"Gong Y.; Wang C.; Jiang Y.; Zhang S.; Feng S.; Fu Y.; Luo Y.; Metformin inhibits tumor metastasis through suppressing Hsp90\u03b1 secretion in an AMPK\u03b11-PKC\u03b3 dependent manner. Cells  2020,9(1),144","journal-title":"Cells"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"jcs228213","DOI":"10.1242\/jcs.228213","volume":"132","author":"Tian Y.","year":"2019","unstructured":"Tian Y.; Wang C.; Chen S.; Liu J.; Fu Y.; Luo Y.; Extracellular Hsp90\u03b1 and clusterin synergistically promote breast cancer epithelial-to-mesenchymal transition and metastasis via LRP1. J Cell Sci  2019,132(15),jcs228213","journal-title":"J Cell Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"21288","DOI":"10.1073\/pnas.0908151106","volume":"106","author":"Wang X.","year":"2009","unstructured":"Wang X.; Song X.; Zhuo W.; Fu Y.; Shi H.; Liang Y.; Tong M.; Chang G.; Luo Y.; The regulatory mechanism of Hsp90\u03b1 secretion and its function in tumor malignancy. Proc Natl Acad Sci USA  2009,106(50),21288-21293","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"Yuan H.","year":"2019","unstructured":"Yuan H.; Yan M.; Zhang G.; Liu W.; Deng C.; Liao G.; Xu L.; Luo T.; Yan H.; Long Z.; Shi A.; Zhao T.; Xiao Y.; Li X.; CancerSEA: A cancer single-cell state atlas. Nucleic Acids Res  2019,47(D1),D900-D908","journal-title":"Nucleic Acids Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"Bindea G.","year":"2013","unstructured":"Bindea G.; Mlecnik B.; Tosolini M.; Kirilovsky A.; Waldner M.; Obenauf A.C.; Angell H.; Fredriksen T.; Lafontaine L.; Berger A.; Bruneval P.; Fridman W.H.; Becker C.; Pag\u00e8s F.; Speicher M.R.; Trajanoski Z.; Galon J.; Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity  2013,39(4),782-795","journal-title":"Immunity"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"870726","DOI":"10.3389\/fimmu.2022.870726","volume":"13","author":"Liang X.","year":"2022","unstructured":"Liang X.; Li L.; Fan Y.; Diagnostic, prognostic, and immunological roles of hells in pan-cancer: A bioinformatics analysis. Front Immunol  2022,13,870726","journal-title":"Front Immunol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11010-020-03896-3","volume":"476","author":"Yu L.L.","year":"2021","unstructured":"Yu L.L.; Wang Y.; Xiao Z.K.; Chen S.S.; Heat shock protein B8 promotes proliferation and migration in lung adenocarcinoma A549 cells by maintaining mitochondrial function. Mol Cell Biochem  2021,476(1),187-197","journal-title":"Mol Cell Biochem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ijc.29509","volume":"138","author":"Mazaira G.I.","year":"2016","unstructured":"Mazaira G.I.; Camisay M.F.; De Leo S.; Erlejman A.G.; Galigniana M.D.; Biological relevance of Hsp90-binding immunophilins in cancer development and treatment. Int J Cancer  2016,138(4),797-808","journal-title":"Int J Cancer"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1016\/j.ajpath.2020.04.012","volume":"190","author":"Wang S.","year":"2020","unstructured":"Wang S.; Zhang X.; Wang H.; Wang Y.; Chen P.; Wang L.; Heat shock protein 27 enhances SUMOylation of heat shock protein B8 to accelerate the progression of breast cancer. Am J Pathol  2020,190(12),2464-2477","journal-title":"Am J Pathol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s13205-022-03422-w","volume":"13","author":"Alagundagi DB","year":"2023","unstructured":"Alagundagi DB; Ghate SD; Rajendra V; Gollapalli P; Shetty VV; D'Souza C; Shetty P; Patil P; Exploring breast cancer exosomes for novel biomarkers of potential diagnostic and prognostic importance. 3 Biotech  2023,13(1),7","journal-title":"3 Biotech"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"963719","DOI":"10.3389\/fonc.2022.963719","volume":"12","author":"Yuan Z.","year":"2022","unstructured":"Yuan Z.; Wang L.; Chen C.; Analysis of the prognostic, diagnostic and immunological role of HSP90\u03b1 in malignant tumors. Front Oncol  2022,12,963719","journal-title":"Front Oncol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"107424","DOI":"10.1016\/j.compbiomed.2023.107424","volume":"165","author":"Rehman A.","year":"2023","unstructured":"Rehman A.; Fatima I.; Wang Y.; Tong J.; Noor F.; Qasim M.; Peng Y.; Liao M.; Unveiling the multi-target compounds of Rhazya stricta: Discovery and inhibition of novel target genes for the treatment of clear cell renal cell carcinoma. Comput Biol Med  2023,165,107424","journal-title":"Comput Biol Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/MEG.0b013e3280102f78","volume":"19","author":"Kumar Y.","year":"2007","unstructured":"Kumar Y.; Tapuria N.; Kirmani N.; Davidson B.R.; Tumour M2-pyruvate kinase: A gastrointestinal cancer marker. Eur J Gastroenterol Hepatol  2007,19(3),265-276","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/cancers15010261","volume":"15","author":"Lumbreras B.","year":"2022","unstructured":"Lumbreras B.; Parker L.A.; Caballero-Romeu J.P.; G\u00f3mez-P\u00e9rez L.; Puig-Garc\u00eda M.; L\u00f3pez-Garrig\u00f3s M.; Garc\u00eda N.; Hern\u00e1ndez-Aguado I.; Variables associated with false-positive psa results: A cohort study with real-world data. Cancers  2022,15(1),261","journal-title":"Cancers"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13046-018-0880-6","volume":"37","author":"Xiao X.","year":"2018","unstructured":"Xiao X.; Wang W.; Li Y.; Yang D.; Li X.; Shen C.; Liu Y.; Ke X.; Guo S.; Guo Z.; HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma. J Exp Clin Cancer Res  2018,37(1),201","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s40425-019-0646-5","volume":"7","author":"Chen Y.Q.","year":"2019","unstructured":"Chen Y.Q.; Li P.C.; Pan N.; Gao R.; Wen Z.F.; Zhang T.Y.; Huang F.; Wu F.Y.; Ou X.L.; Zhang J.P.; Zhu X.J.; Hu H.M.; Chen K.; Cai Y.L.; Wang L.X.; Tumor-released autophagosomes induces CD4\n\nT cell-mediated immunosuppression via a TLR2\u2013IL-6 cascade. J Immunother Cancer  2019,7(1),178","journal-title":"J Immunother Cancer"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/ncomms1675","volume":"3","author":"Li G.","year":"2012","unstructured":"Li G.; Ji X.D.; Gao H.; Zhao J.S.; Xu J.F.; Sun Z.J.; Deng Y.Z.; Shi S.; Feng Y.X.; Zhu Y.Q.; Wang T.; Li J.J.; Xie D.; EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A\/RACK1\/Akt signalling complex. Nat Commun  2012,3(1),667","journal-title":"Nat Commun"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"724192","DOI":"10.3389\/fphar.2021.724192","volume":"12","author":"Niu M.","year":"2022","unstructured":"Niu M.; Zhang B.; Li L.; Su Z.; Pu W.; Zhao C.; Wei L.; Lian P.; Lu R.; Wang R.; Wazir J.; Gao Q.; Song S.; Wang H.; Targeting hsp90 inhibits proliferation and induces apoptosis through akt1\/erk pathway in lung cancer. Front Pharmacol  2022,12,724192","journal-title":"Front Pharmacol"},{"key":"ref=30","first-page":"8420","volume":"63","author":"Rahmani M.","year":"2003","unstructured":"Rahmani M.; Yu C.; Dai Y.; Reese E.; Ahmed W.; Dent P.; Grant S.; Coadministration of the heat shock protein 90 antagonist 17-allylamino- 17-demethoxygeldanamycin with suberoylanilide hydroxamic acid or sodium butyrate synergistically induces apoptosis in human leukemia cells. Cancer Res  2003,63(23),8420-8427","journal-title":"Cancer Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1593\/tlo.13292","volume":"6","author":"Friedman J.A.","year":"2013","unstructured":"Friedman J.A.; Wise S.C.; Hu M.; Gouveia C.; Broek R.V.; Freudlsperger C.; Kannabiran V.R.; Arun P.; Mitchell J.B.; Chen Z.; Van Waes C.; Hsp90 inhibitor snx5422\/2112 targets the dysregulated signal and transcription factor network and malignant phenotype of head and neck squamous cell carcinoma. Transl Oncol  2013,6(4),429-IN5","journal-title":"Transl Oncol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.cell.2022.03.033","volume":"185","author":"Baldominos P.","year":"2022","unstructured":"Baldominos P.; Barbera-Mourelle A.; Barreiro O.; Huang Y.; Wight A.; Cho J.W.; Zhao X.; Estivill G.; Adam I.; Sanchez X.; McCarthy S.; Schaller J.; Khan Z.; Ruzo A.; Pastorello R.; Richardson E.T.; Dillon D.; Montero-Llopis P.; Barroso-Sousa R.; Forman J.; Shukla S.A.; Tolaney S.M.; Mittendorf E.A.; von Andrian U.H.; Wucherpfennig K.W.; Hemberg M.; Agudo J.; Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche. Cell  2022,185(10),1694-1708.e19","journal-title":"Cell"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-94-017-9487-9_3","volume":"841","author":"Zhang Y.","year":"2014","unstructured":"Zhang Y.; Zhang Y.; Gu W.; He L.; Sun B.; Th1\/Th2 cell\u2019s function in immune system. Adv Exp Med Biol  2014,841,45-65","journal-title":"Adv Exp Med Biol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1186\/s12967-022-03807-8","volume":"20","author":"Chen Y.","year":"2022","unstructured":"Chen Y.; Sun J.; Luo Y.; Liu J.; Wang X.; Feng R.; Huang J.; Du H.; Li Q.; Tan J.; Ren G.; Wang X.; Li H.; Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer. J Transl Med  2022,20(1),615","journal-title":"J Transl Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.cell.2016.01.049","volume":"164","author":"Palucka A.K.","year":"2016","unstructured":"Palucka A.K.; Coussens L.M.; The basis of oncoimmunology. Cell  2016,164(6),1233-1247","journal-title":"Cell"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1084\/jem.20101876","volume":"208","author":"De Monte L.","year":"2011","unstructured":"De Monte L.; Reni M.; Tassi E.; Clavenna D.; Papa I.; Recalde H.; Braga M.; Di Carlo V.; Doglioni C.; Protti M.P.; Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med  2011,208(3),469-478","journal-title":"J Exp Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","volume":"18","author":"Myers J.A.","year":"2021","unstructured":"Myers J.A.; Miller J.S.; Exploring the NK cell platform for cancer immunotherapy. Nat Rev Clin Oncol  2021,18(2),85-100","journal-title":"Nat Rev Clin Oncol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"11991","DOI":"10.1158\/0008-5472.CAN-07-2068","volume":"67","author":"Varchetta S.","year":"2007","unstructured":"Varchetta S.; Gibelli N.; Oliviero B.; Nardini E.; Gennari R.; Gatti G.; Silva L.S.; Villani L.; Tagliabue E.; M\u00e9nard S.; Costa A.; Fagnoni F.F.; Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2. Cancer Res  2007,67(24),11991-11999","journal-title":"Cancer Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1200\/JCO.2003.05.013","volume":"21","author":"Weng W.K.","year":"2003","unstructured":"Weng W.K.; Levy R.; Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. J Clin Oncol  2003,21(21),3940-3947","journal-title":"J Clin Oncol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","volume":"9","author":"Castro F.","year":"2018","unstructured":"Castro F.; Cardoso A.P.; Gon\u00e7alves R.M.; Serre K.; Oliveira M.J.; Interferon-gamma at the crossroads of tumor immune surveillance or evasion. Front Immunol  2018,9,847","journal-title":"Front Immunol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.3892\/mmr.2018.9306","volume":"18","author":"Zhu Y.D.","year":"2018","unstructured":"Zhu Y.D.; Lu M.Y.; Increased expression of TNFRSF14 indicates good prognosis and inhibits bladder cancer proliferation by promoting apoptosis. Mol Med Rep  2018,18(3),3403-3410","journal-title":"Mol Med Rep"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"765115","DOI":"10.3389\/fonc.2021.765115","volume":"11","author":"Chen S.","year":"2021","unstructured":"Chen S.; Yu Q.; Zhou S.; Plasmatic levels of HSP90\u03b1 at diagnosis: A novel prognostic indicator of clinical outcome in advanced lung cancer patients treated with PD-1\/PD-L1 inhibitors plus chemotherapy. Front Oncol  2021,11,765115","journal-title":"Front Oncol"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673378694251003073322","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/251197\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673378694251003073322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:59:10Z","timestamp":1791878350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/251197\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":42,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673378694251003073322","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-02-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}